Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 623.75 Million CNY | -32.42% |
| 2022 | 939.12 Million CNY | -1.01% |
| 2021 | 948.72 Million CNY | -29.92% |
| 2020 | 1.35 Billion CNY | 90.76% |
| 2019 | 709.65 Million CNY | 35.88% |
| 2018 | 522.27 Million CNY | 130.72% |
| 2017 | 226.36 Million CNY | 29.48% |
| 2016 | 174.82 Million CNY | -4.4% |
| 2015 | 182.87 Million CNY | -32.71% |
| 2014 | 271.76 Million CNY | -0.37% |
| 2013 | 272.77 Million CNY | 13.51% |
| 2012 | 240.3 Million CNY | -26.66% |
| 2011 | 327.67 Million CNY | 2.98% |
| 2010 | 318.18 Million CNY | 21.23% |
| 2009 | 262.46 Million CNY | 33.99% |
| 2008 | 195.88 Million CNY | 27.3% |
| 2007 | 153.87 Million CNY | 25.98% |
| 2006 | 122.13 Million CNY | 72.4% |
| 2005 | 70.84 Million CNY | 6.18% |
| 2004 | 66.72 Million CNY | 43.5% |
| 2003 | 46.49 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 154.97 Million CNY | 23.22% |
| 2024 Q2 | 125.77 Million CNY | -18.98% |
| 2024 Q1 | 155.23 Million CNY | -17.31% |
| 2023 Q1 | 166.88 Million CNY | -45.69% |
| 2023 Q2 | 126.89 Million CNY | -23.96% |
| 2023 Q3 | 153.15 Million CNY | 20.7% |
| 2023 Q4 | 187.72 Million CNY | 22.57% |
| 2023 FY | 634.67 Million CNY | -32.42% |
| 2022 Q2 | 162.33 Million CNY | -1.9% |
| 2022 FY | 939.12 Million CNY | -1.01% |
| 2022 Q3 | 304.05 Million CNY | 87.29% |
| 2022 Q4 | 307.26 Million CNY | 1.06% |
| 2022 Q1 | 165.47 Million CNY | -47.05% |
| 2021 FY | 948.72 Million CNY | -29.92% |
| 2021 Q1 | 187.72 Million CNY | -56.51% |
| 2021 Q2 | 230.47 Million CNY | 22.77% |
| 2021 Q3 | 218.02 Million CNY | -5.4% |
| 2021 Q4 | 312.5 Million CNY | 43.34% |
| 2020 Q3 | 359.01 Million CNY | 7.83% |
| 2020 Q4 | 431.64 Million CNY | 20.23% |
| 2020 Q1 | 230.12 Million CNY | -6.98% |
| 2020 Q2 | 332.93 Million CNY | 44.68% |
| 2020 FY | 1.35 Billion CNY | 90.76% |
| 2019 Q4 | 247.38 Million CNY | 48.96% |
| 2019 Q1 | 125.05 Million CNY | -30.33% |
| 2019 Q2 | 171.13 Million CNY | 36.84% |
| 2019 Q3 | 166.07 Million CNY | -2.95% |
| 2019 FY | 709.65 Million CNY | 35.88% |
| 2018 Q3 | 135.27 Million CNY | 2.06% |
| 2018 Q4 | 179.48 Million CNY | 32.69% |
| 2018 FY | 522.27 Million CNY | 130.72% |
| 2018 Q1 | 74.96 Million CNY | -6.92% |
| 2018 Q2 | 132.54 Million CNY | 76.8% |
| 2017 Q3 | 65.63 Million CNY | 39.3% |
| 2017 Q2 | 47.11 Million CNY | 42.44% |
| 2017 Q1 | 33.07 Million CNY | -3.09% |
| 2017 FY | 226.36 Million CNY | 29.48% |
| 2017 Q4 | 80.54 Million CNY | 22.73% |
| 2016 Q1 | 37.35 Million CNY | 88.71% |
| 2016 FY | 174.82 Million CNY | -4.4% |
| 2016 Q4 | 34.13 Million CNY | -26.0% |
| 2016 Q3 | 46.12 Million CNY | -19.4% |
| 2016 Q2 | 57.22 Million CNY | 53.21% |
| 2015 Q4 | 19.79 Million CNY | -65.21% |
| 2015 Q1 | 35.74 Million CNY | -49.61% |
| 2015 FY | 182.87 Million CNY | -32.71% |
| 2015 Q2 | 70.43 Million CNY | 97.05% |
| 2015 Q3 | 56.89 Million CNY | -19.23% |
| 2014 FY | 271.76 Million CNY | -0.37% |
| 2014 Q3 | 73.53 Million CNY | -4.85% |
| 2014 Q1 | 50 Million CNY | -40.26% |
| 2014 Q4 | 70.94 Million CNY | -3.53% |
| 2014 Q2 | 77.28 Million CNY | 54.53% |
| 2013 Q3 | 64.22 Million CNY | -9.72% |
| 2013 Q1 | 53.7 Million CNY | -22.51% |
| 2013 Q2 | 71.14 Million CNY | 32.48% |
| 2013 Q4 | 83.71 Million CNY | 30.34% |
| 2013 FY | 272.77 Million CNY | 13.51% |
| 2012 FY | 240.3 Million CNY | -26.66% |
| 2012 Q3 | 54.61 Million CNY | -16.14% |
| 2012 Q2 | 65.12 Million CNY | 27.06% |
| 2012 Q1 | 51.25 Million CNY | -29.74% |
| 2012 Q4 | 69.29 Million CNY | 26.89% |
| 2011 Q1 | 74.83 Million CNY | -24.7% |
| 2011 FY | 327.67 Million CNY | 2.98% |
| 2011 Q2 | 94.01 Million CNY | 25.64% |
| 2011 Q4 | 72.95 Million CNY | -15.04% |
| 2011 Q3 | 85.86 Million CNY | -8.67% |
| 2010 Q2 | 75.69 Million CNY | 28.11% |
| 2010 Q4 | 99.37 Million CNY | 18.26% |
| 2010 Q1 | 59.08 Million CNY | -28.38% |
| 2010 Q3 | 84.02 Million CNY | 11.01% |
| 2010 FY | 318.18 Million CNY | 21.23% |
| 2009 FY | 262.46 Million CNY | 33.99% |
| 2009 Q4 | 82.49 Million CNY | 3.74% |
| 2009 Q3 | 79.52 Million CNY | 20.55% |
| 2009 Q2 | 65.96 Million CNY | 91.32% |
| 2009 Q1 | 34.47 Million CNY | -15.71% |
| 2008 FY | 195.88 Million CNY | 27.3% |
| 2008 Q3 | 57.28 Million CNY | 1.58% |
| 2008 Q1 | 41.29 Million CNY | -6.51% |
| 2008 Q2 | 56.39 Million CNY | 36.56% |
| 2008 Q4 | 40.9 Million CNY | -28.59% |
| 2007 Q2 | 41.48 Million CNY | 62.03% |
| 2007 Q4 | 44.17 Million CNY | 3.66% |
| 2007 Q1 | 25.6 Million CNY | -40.35% |
| 2007 FY | 153.87 Million CNY | 25.98% |
| 2007 Q3 | 42.61 Million CNY | 2.73% |
| 2006 Q4 | 42.92 Million CNY | 31.59% |
| 2006 Q3 | 32.61 Million CNY | 5.1% |
| 2006 Q2 | 31.03 Million CNY | 99.45% |
| 2006 Q1 | 15.56 Million CNY | -28.63% |
| 2006 FY | 122.13 Million CNY | 72.4% |
| 2005 Q3 | 18.93 Million CNY | 0.0% |
| 2005 Q4 | 21.8 Million CNY | 15.13% |
| 2005 FY | 70.84 Million CNY | 6.18% |
| 2004 FY | 66.72 Million CNY | 43.5% |
| 2003 FY | 46.49 Million CNY | 0.0% |